Johns Hopkins Bayview Medical Center is teaching hospital trauma center, neonatal intensive care unit, geriatrics center, and is home to the Johns Hopkins Burn Center, the only adult burn trauma in Maryland, containing about 420 beds.

There are 420 beds in Johns Hopkins Bayview Medical Center.

During the past decade, Johns Hopkins Bayview Medical Center conducted 145 clinical trials. In the 10-year time frame, 145 clinical trials started and 70 clinical trials were completed, i.e. on average, 48.3% percent of trials that started reached the finish line to date. In the past 5 years, 72 clinical trials started and 29 clinical trials were completed. i.e. 40.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Johns Hopkins Bayview Medical Center" #1 sponsor was "Johns Hopkins University" with 142 trials, followed by "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins" with 12 trials sponsored, "Health Decisions" with 5 trials sponsored, "National Cancer Institute (NCI)" with 5 trials sponsored and "National Heart, Lung, and Blood Institute (NHLBI)" with 5 trials sponsored. Other sponsors include 91 different institutions and companies that sponsored additional 79 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Johns Hopkins Bayview Medical Center" #1 collaborator was "National Institute on Drug Abuse (NIDA)" with 17 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 13 trials as a collaborator, "Johns Hopkins University" with 12 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 7 trials as a collaborator and "National Institute on Aging (NIA)" with 7 trials as a collaborator. Other collaborators include 156 different institutions and companies that were collaborators in the rest 127 trials.

According to Clinical.Site data, the most researched conditions in "Johns Hopkins Bayview Medical Center" are "Gastroparesis" (9 trials), "Contraception" (6 trials), "Obesity" (6 trials), "Stroke" (6 trials) and "COVID-19" (5 trials). Many other conditions were trialed in "Johns Hopkins Bayview Medical Center" in a lesser frequency.

Most popular intervention types in "Johns Hopkins Bayview Medical Center" are "Drug" (109 trials), "Behavioral" (43 trials), "Other" (41 trials), "Device" (40 trials) and "Procedure" (24 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (38 trials), "Laboratory Biomarker Analysis" (4 trials), "Entinostat" (3 trials), "Ozanimod" (3 trials) and "Treatment as Usual" (3 trials). Other intervention names were less common.

The vast majority of trials in "Johns Hopkins Bayview Medical Center" are 228 trials for "All" genders, 32 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are 65 active trials in "Johns Hopkins Bayview Medical Center". 2 are not yet recruiting, 37 are recruiting, 22 are Active, not recruiting, and 4 are Enrolling by invitation. In total, there were 137 completed trials in Johns Hopkins Bayview Medical Center, 3 suspended trials, and 39 terminated clinical trials to date.

Out of the total trials that were conducted in Johns Hopkins Bayview Medical Center, 14 "Phase 1" clinical trials were conducted, 75 "Phase 2" clinical trials and 43 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 15 trials, and there were also 96 trials that are defined as “Not Applicable".